PPT-Update in
Myeloproliferative Neoplasms January 20 2012 November 16 2011 FDA Indications for Ruxolitinib Jakafi Intermediate or highrisk Myelofibrosis 8090 of MF patients JAK2V617F
Download Presentation
"Update in" is the property of its rightful owner. Permission is granted to download and print materials on this website for personal, non-commercial use only, provided you retain all copyright notices. By downloading content from our website, you accept the terms of this agreement.
Presentation Transcript
Transcript not available.